Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2501 USD | -6.43% | -18.27% | -41.85% |
May. 23 | Theriva Biologics Gets Fast Track Designation for Pancreatic Cancer Treatment | MT |
May. 23 | Theriva Biologics, Inc Announces U.S. Food and Drug Administration Granted Fast Track Designation | CI |
Business Summary
Number of employees: 22
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 15-05-31 | |
Michael Kaleko
CTO | Chief Tech/Sci/R&D Officer | - | 12-02-29 |
- | - | ||
T. J. Swope
SEC | Corporate Secretary | - | - |
Manel Cascalló
PRN | Corporate Officer/Principal | - | 22-03-22 |
Vince Wacher
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Wolf
BRD | Director/Board Member | 60 | 05-12-31 |
John Monahan
BRD | Director/Board Member | 77 | 20-11-10 |
Jeffrey Kraws
CHM | Chairman | 59 | 05-12-31 |
Chief Executive Officer | 62 | 15-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,997,604 | 16,946,072 ( 94.16 %) | 720,233 ( 4.002 %) | 94.16 % |
Company contact information
Theriva Biologics, Inc.
9605 Medical Center Drive Suite 270
20850, Rockville
+301 417 4364
http://www.therivabio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.85% | 4.32M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- TOVX Stock
- Company Theriva Biologics, Inc.